Bolt Biotherapeutics, Inc.
BOLT
Revenue
1.28M
▼-4.00M▼-75.82%
3 Months ChangeAssets
124.18M
▼-18.72M▼-13.10%
3 Months ChangeLiabilities
38.32M
▼-417.00k▼-1.08%
3 Months ChangeFree Cash Flow
-16.75M
▲6.65M▲28.42%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-09-04
Form 8-K
ID: 0001193125-24-213225
2024-08-13
Form 10-Q
ID: 0000950170-24-096200
2024-08-13
Form 8-K
ID: 0000950170-24-096191
2024-07-03
Form 8-K
ID: 0001193125-24-175113
2024-06-14
Form 8-K
ID: 0000950170-24-073501
2024-05-14
Form 10-Q
ID: 0000950170-24-059564
2024-05-14
Form 8-K
ID: 0000950170-24-059524
2024-03-21
Form 8-K
ID: 0000950170-24-034688
2023-11-09
Form 10-Q
ID: 0000950170-23-062048
2023-11-09
Form 8-K
ID: 0000950170-23-062027